Tag: Vaccines
Global Coverage With Measles Vaccine Declined During COVID-19
From 2022 to 2023, there was a 20 percent increase in estimated measles cases worldwide, from 8,645,000 to 10,341,000
Neoantigen DNA Vaccines Safe, Induce Response in Triple-Negative Breast Cancer
Fourteen of 18 patients had neoantigen-specific T-cell responses; recurrence-free survival was 87.5 percent at 36 months
Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu Shots
Primary composite reactogenicity outcome noninferior for those receiving both vaccines simultaneously
RSV Vaccination Prevents Associated Hospitalization, Emergency Encounters
Respiratory syncytial virus vaccination effective for adults aged at least 60 years
Pandemic-Linked Worldwide Declines in Childhood Vaccination Not Yet Recovered
Global coverage with first and third doses of DTPcv and measles-containing vaccine stagnated during 2022-2023
Flu Vaccine Coverage 80.7 Percent for Health Workers in Acute Care Hospitals
Coverage lower among health care personnel at nursing homes, while coverage for COVID-19 2023-24 vaccine was much lower
CDC Says Some People May Need Extra Dose of COVID Vaccine
CDC Lowers Age for First Pneumococcal Vaccine to 50
IDSA: Vaccination Less Likely With Increasing Social Vulnerability, Black Race
Lower likelihood of vaccination for flu, SARS-CoV-2, RSV seen with increasing quartile of social vulnerability index, especially for Black people
Complete Vaccination Coverage Down in Kindergarteners for 2023-24 School Year
Simultaneously, exemptions increased in most U.S. jurisdictions
